Advanced search
Publication Cover
Free Radical Research Communications Volume 11, 1990 - Issue 1-3
Journal homepage
11
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Release of Iron from Ferritin by 6-Hydroxydopamine Under Aerobic and Anaerobic Conditions

H. N. Lode Children's Hospital, Dept. Hematology and Oncology, University of Tuebingen, D-7400, Tuebingen, FRG
,
G. Bruchelt Children's Hospital, Dept. Hematology and Oncology, University of Tuebingen, D-7400, Tuebingen, FRG
,
A. G. Rieth Children's Hospital, Dept. Hematology and Oncology, University of Tuebingen, D-7400, Tuebingen, FRG
&
D. Niethammer Children's Hospital, Dept. Hematology and Oncology, University of Tuebingen, D-7400, Tuebingen, FRG
Pages 153-158 | Received 15 Dec 1989, Published online: 07 Jul 2009

References

  • Kostrezewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacology Review 1974; 26: 199–288
  • Sachs C., Jonsson G. Mechanisms of action of 6-hydroxydopamine. Biochemical Pharmacology 1975; 24: 1–8
  • Graham D. G., Tiffany S. M., Bell W. M., Gutknecht W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cell. in vitro. Molecular Pharmacology 1978; 14: 644–653
  • Gee P., Davison A. J. Effects of scavengers of oxygen free radicals on the anaerobic oxidation of 6-hydroxydopamine by H2O2. Biochemica et Biophysica Acta 1985; 838: 183–190
  • Gee P., Davison A. J. Intermediates in the aerobic autoxidation of 6-hydroxydopamine: Relative importance under different reaction conditions. J. Free. Radic. Biol. Med. 1989; 6: 271–284
  • Cohen G., Heikkila R. E. Degeneration of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 1974; 249: 2447–2452
  • Zaizen Y., Nakagawara A., Ikeda K. Patterns of destruction of mouse neuroblastoma cells by extracellular hydrogen peroxide formed by 6-hydroxydopamine and ascorbate. J. Cancer Res. Clin. Oncol. 1986; 111: 93–97
  • Reynolds C. P., Reynolds D. A., Frenkel E. P., Smith R. G. Selective toxicity of 6-hyroxydopamine and ascorbate for human neuroblastoma in vitro: A model for clearing marrow prior to autologous transplant. Cancer Research 1982; 42: 1331–1336
  • Iancu T. C., Shilo H., Kedar A. Neuroblastomas contain iron-rich ferritin. Cancer 1988; 61: 2497–2502
  • Samokyszyn V. M., Thomas C. E., Reif D. W., Saito M., Aust S. D. Release of iron from ferritin and its role in oxygen radical toxicities. Drug Metabolic Review 1988; 19: 283–303
  • Monteiro H. P., Vile G. F., Winterbourn C. C. Release of iron from ferritin by semiquinone, anthracycline, bipyridyl, an nitroaromatic radicals. Journal of Free Radicals in Biological Medicine 1989; 6: 587–591
  • Biemont P., VanEijk H. G., Swaak A. J.G., Koster J. F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphnuclear leukocytes. Journal of Clinical Investigation 1988; 73: 1576–1579
  • Boyer R. F., Grabill T. W., Petrowich R. M. Reductive release of ferritin iron: A kinetic assay. Analytical Biochemistry 1988; 174: 17–22
  • Stookey L. L. Ferrozine-A new spectrophotometric reagent for iron. Analytical Chemistry 1970; 42: 779–781
  • Heikkila R. E., Cohen G. Prevention of 6-OHDA induced neurotoxicity. Chemical tools in catecholamine research, Vol. 1, G. Jonsson, T. Malmfors, C. Sachs. North-Holland Publishing Company. 1975; 7–14
  • Monteiro H. P., Winterbourn C. C. The superoxide-dependent transfer of iron from ferritin to transferrin and lactoferrin. Biochemical Journal 1988; 256: 923–928
  • Koster J. F., Slee R. G. Ferritin, a physiological iron donor for microsomal lipid peroxidation. FEBS Lett. 1986; 199: 85–88
  • Reif D. W., Schubert F., Aust S. D. Iron release from ferritin and lipid peroxidation by radiolytically generated reducing radicals. Arch. Biochem. Biophys. 1988; 264: 238–243
  • Buck J., Bruchelt G., Girgert R., Treuner J., Niethammer D. Specific uptake of m-[125I] iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Research 1985; 45: 6366–6370

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.